Meta-Analysis
Copyright ©The Author(s) 2023.
World J Meta-Anal. Jun 18, 2023; 11(5): 228-252
Published online Jun 18, 2023. doi: 10.13105/wjma.v11.i5.228
Table 3 Lung cancer and current vs never cigarette smoking – results from random effects meta-analyses
Full output table
Factor
Level
No. of RRs
No. of studies
RR (95%CI)
Heterogeneity test by level (NS = P ≥ 0.1) and trend if relevant
All624412.14 (10.30-14.30)P < 0.001
4SexCombined121212.93 (10.55-15.84)
Males262612.95 (9.82-17.08)
Females242411.32 (8.46-15.15)NS
5RegionN. America342615.15 (12.77-17.96)
Europe211412.30 (9.77-15.49)
Japan633.61 (2.87-4.55)
Multi1113.10 (9.91-17.32)P < 0.001
6Study populationInternational3214.45 (6.85-30.50)
National251610.26 (8.03-13.12)
Regional241716.27 (13.39-19.77)
Specific1099.71 (5.41-17.42)P < 0.05
7Year of start of baseline< 198014108.65 (5.83-12.83)
1980-89191312.92 (9.83-16.98)
1990-99161213.45 (9.76-18.53)
2000+13914.38 (11.40-18.15)NS trend P < 0.1
8Number of cases< 500191611.90 (9.55-14.83)
500-1999241711.68 (8.65-15.75)
2000+191112.76 (9.99-16.31)NS trend NS
9Exclusive cigarettesNo453513.47 (11.55-15.72)
Yes17119.50 (6.61-13.64)P < 0.1
10Latency rule appliedNo513811.93 (9.97-14.28)
Yes11713.13 (8.69-19.83)NS
11Study designCohort553912.35 (10.35-14.73)
Nested case control7510.41 (8.04-13.48)NS
12, 13Lowest age considered< 30151011.30 (7.37-17.33)
30-3911811.41 (7.80-16.70)
40-4814913.29 (9.15-19.30)
49+141013.62 (10.22-18.16)NS trend without
Missing8810.79 (7.64-15.23)Missing NS
14Year of follow-up< 1011712.63 (8.49-18.80)
10- < 1511816.05 (12.48-20.65)
15- < 20141116.05 (12.69-20.30)
20- < 3015119.08 (6.26-13.15)
30+1189.57 (6.01-15.26)P < 0.05 trend P < 0.1
15EndpointDied231714.85 (11.99-18.38)
Diagnosed392710.82 (8.61-13.60)P < 0.05
16Number of adjustment factorsNone20159.65 (7.13-13.05)
Age only4311.80 (5.24-26.56)
More382813.68 (11.46-16.34)NS trend P < 0.1